Mirae Asset Global Etfs Holdings Ltd. Recursion Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 157,123 shares of RXRX stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
157,123
Previous 84,941
84.98%
Holding current value
$1.18 Million
Previous $637,000
62.48%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
303Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$242 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$186 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$182 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$130 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$115 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.35B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...